Skip to main content

Table 1 Diagnostic criteria for COVID-19-associated pulmonary aspergillosis (CAPA) according to ECMM/ ISHAM [5]

From: Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience

 

Host factors

Clinical factors

Mycological evidence

Tracheobronchitis or other pulmonary forms (proven)

Patients with COVID-19 needing intensive care and a temporal relationship (entry criterion)

 

At least one of the following: Histopathological or direct microscopic detection of fungal hyphae, showing tissue damage; or aspergillus recovered by culture or microscopy or histology or PCR obtained by a sterile aspiration or biopsy

Tracheobronchitis (probable)

Patients with COVID-19 needing intensive care and a temporal relationship (entry criterion)

Tracheobronchitis, indicated by tracheobronchial ulceration, nodule, pseudomembrane, plaque, or eschar seen on bronchoscopic analysis

At least one of the following: Microscopic detection of fungal elements in bronchoalveolar lavage; positive bronchoalveolar lavage culture or PCR; serum galactomannan index > 0.5 or serum LFA index > 0.5; or bronchoalveolar lavage galactomannan index ≥ 1.0 or bronchoalveolar lavage LFA index ≥ 1.0

Other pulmonary forms (probable)

Patients with COVID-19 needing intensive care and a temporal relationship (entry criterion)

Pulmonary infiltrate, preferably documented by chest CT, or cavitating infiltrate (not attributed to another cause)

At least one of the following: Microscopic detection of fungal elements in bronchoalveolar lavage; positive bronchoalveolar lavage culture; serum galactomannan index > 0.5 or serum LFA index > 0.5; bronchoalveolar lavage galactomannan index ≥ 1.0 or bronchoalveolar lavage LFA index ≥ 1.0; two or more positive aspergillus PCR tests in plasma, serum, or whole blood; a single positive aspergillus PCR in bronchoalveolar lavage fluid

Other pulmonary forms (possible)

Patients with COVID-19 needing intensive care and a temporal relationship (entry criterion)

Pulmonary infiltrate, preferably documented by chest CT, or cavitating infiltrate (not attributed to another cause)

At least one of the following: Microscopic detection of fungal elements in non-bronchoscopic lavage; positive non-bronchoscopic lavage culture; single non-bronchoscopic lavage galactomannan index > 4.5; non-bronchoscopic lavage galactomannan index > 1.2 twice or more; or non-bronchoscopic lavage galactomannan index > 1.2 plus another non-bronchoscopic lavage mycology test positive

  1. CAPA COVID-19-associated pulmonary aspergillosis, COVID-19 Coronavirus-2019, ECMM/ ISHAM European Confederation of Medical Mycology (ECMM) and the International Society for Human and Animal Mycology 2020, PCR polymerase chain reaction, CT computed tomography, LFA lateral flow assay